Trademark: 97520536
Word
GANDEEVA THERAPEUTICS
Status Date
Tuesday, March 19, 2024
Filing Date
Tuesday, July 26, 2022
Published for Opposition
Tuesday, August 1, 2023
9 Downloadable and recorded medical software for drug discovery; Downloadable and recorded software for analyzing microscopy data; Downloadable and recorded computer programs using artificial intelligence for use in machine learning; Downloadable and recorded bioinformatics software; Downloadable and recorded computer application software for in silico drug design and image processing; Downloadable and recorded software for use in the evaluation and analysis of data utilizing machine learning; Downloadable and recorded microscope operating software and microscope accessories in the nature of electron microscope operational parameters, namely, electron beam control, detector apparatus, and sample handling and positioning controls
5 Reagents for medical use; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the treatment of aberrant protein function; Antitumor drugs; chemotherapeutics; Pharmaceutical preparations for the treatment of cancer, neurological, inflammatory or metabolic diseases; Therapeutic agents for the treatment of cancer, neurological, inflammatory or metabolic diseases; Diagnostic biomarker reagents for medical purposes
44 Providing medical information in the field of oncology; Providing medical information in the field of protein interactions and aberrant protein function; Providing pharmaceutical information; Medical analysis services for diagnostic and treatment purposes; Providing information in the field of medicine via a website; Providing information in the field of oncology via a website; providing information and commentary in the field of precision medicine
10 Medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for use in oncology
42 Drug discovery services; Scientific research; Medical oncology research; Scientific study and research in the fields of protein interactions and aberrant protein function; Biological research and analysis; Providing medical and scientific research information; Providing information about medical research via a website; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of structural biology, artificial intelligence and machine learning; Software as a service (SaaS) services featuring software for bioinformatics data analysis; Pharmaceutical drug development services; Biochemical research and analysis; Providing information in the field of drug discovery via a website; Providing information in the field of structural biology via a website
The mark consists of the words "GANDEEVA THERAPEUTICS" together with an arrowhead design on the left.
Color is not claimed as a feature of the mark.
"THERAPEUTICS"
Mar 20, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 19, 2024
Sou Extension 1 Granted
Mar 19, 2024
Sou Extension 1 Filed
Mar 19, 2024
Sou Teas Extension Received
Sep 26, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 1, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 1, 2023
Published For Opposition
Jul 12, 2023
Notification Of Notice Of Publication E-Mailed
Jun 22, 2023
Approved For Pub - Principal Register
Jun 22, 2023
Examiner's Amendment Entered
Jun 22, 2023
Notification Of Examiners Amendment E-Mailed
Jun 22, 2023
Examiners Amendment E-Mailed
Jun 22, 2023
Examiners Amendment -Written
Jun 12, 2023
Previous Allowance Count Withdrawn
Jun 7, 2023
Withdrawn From Pub - Og Review Query
Jun 7, 2023
Notification Of Notice Of Publication E-Mailed
May 22, 2023
Approved For Pub - Principal Register
May 22, 2023
Examiner's Amendment Entered
May 22, 2023
Notification Of Examiners Amendment E-Mailed
May 22, 2023
Examiners Amendment E-Mailed
May 22, 2023
Examiners Amendment -Written
May 11, 2023
Assigned To Examiner
Aug 18, 2022
Notice Of Design Search Code E-Mailed
Aug 17, 2022
New Application Office Supplied Data Entered
Jul 29, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
